Florida Bills Would Require Warning Labels, Dosage Caps, and Lab Testing for All Kratom Products

Why it matters

Florida — which already passed a Kratom Consumer Protection Act — is now considering stricter rules that could pull high-risk products like extracts and kratom-kava blends off store shelves while requiring standardized labeling and lab certification for products that remain.

The big picture

Florida was an early adopter of kratom consumer protection legislation, but a wave of adverse events and family-reported deaths has prompted lawmakers to go further. Senate Bill 994 and House Bill 1205 would extend the state's existing framework by mandating transparent labeling, maximum dosage disclosures, and third-party laboratory testing. Florida's emergency rule already classifies concentrated 7-OH as a Schedule I controlled substance, and the new bills would formalize that and add further safeguards for remaining kratom products.

Key findings

• SB 994 and HB 1205 would require clear health risk warnings and instructions to consult a healthcare provider before use
• Products would be required to disclose alkaloid content so consumers can assess potency
• Kratom processors would need to register with the FDA and obtain permits from the Florida Department of Agriculture
• Every batch of finished product would require independent lab certification for concentration limits and absence of prohibited substances
• Mixed products containing kratom with kava, alcohol, or cannabinoids would likely be pulled from shelves under the new rules
• University of Florida pharmacy researchers say extract products carry high overdose risk because safe dosing is unknown

What they say

"If we look for the safety data, so far, we only have the safety for leaf material. And the extracts, we don't know what the dose, and they are easy to overdose on," said Dr. Abhisheak Sharma of the University of Florida College of Pharmacy.

Bottom line

Florida's proposed bills represent a model for middle-ground kratom regulation: keeping natural leaf products on shelves with strict labeling and testing requirements while banning high-risk extracts and mixed formulations.